Filing Details
- Accession Number:
- 0001209191-20-027885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:19:10
- Reporting Period:
- 2020-05-06
- Accepted Time:
- 2020-05-08 16:19:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735944 | Reshma Kewalramani | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-06 | 1,564 | $187.53 | 28,190 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-06 | 510 | $155.57 | 28,700 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-06 | 416 | $270.35 | 28,284 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 300 | $271.92 | 27,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 360 | $272.77 | 27,624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 864 | $274.04 | 26,760 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 134 | $275.17 | 26,626 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 1,564 | $0.00 | 1,564 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 510 | $0.00 | 510 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,206 | 2029-02-05 | No | 4 | M | Direct | |
| 3,567 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $270.35 (range $269.87 to $270.75).
- Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $271.92 (range $271.33 to $272.17).
- Open market sales reported on this line occurred at a weighted average price of $272.77 (range $272.44 to $273.30).
- Open market sales reported on this line occurred at a weighted average price of $274.04 (range $273.56 to $274.40).
- Open market sales reported on this line occurred at a weighted average price of $275.17 (range $274.60 to $275.30).
- The option vests in 16 quarterly installments from 02/06/2019.
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
